HIV vs Syphilis Rapid Test
Direct answer: HIV rapid tests detect HIV antibodies (or antigen/antibody); syphilis rapid tests detect Treponema pallidum antibodies. They screen two different sexually transmitted infections that share risk groups and are frequently tested together.
Comparison table
| HIV test | Syphilis test | |
|---|---|---|
| Target | HIV-1/2 antibodies (or p24 antigen) | Treponema pallidum antibodies |
| Window period | ~3–6 weeks | ~2–6 weeks |
| Reactive means | Presumptive HIV — needs confirmation | Exposure — needs non-treponemal (RPR) to stage |
| Specimen | WB / serum / plasma / oral fluid | WB / serum / plasma |
What each test detects
- HIV: antibodies to HIV-1/2 (or p24 antigen in antigen/antibody combos).
- Syphilis: treponemal antibodies that persist after treatment — do not distinguish active from past infection alone.
Strengths
- HIV: first-line screening; antigen/antibody combos narrow the window period.
- Syphilis: treponemal tests are highly sensitive for exposure screening.
Limitations
- HIV: window period; reactive results require confirmation.
- Syphilis: treponemal antibodies stay positive after treatment; need RPR titer for staging.
False positive / negative considerations
- HIV false positive: rare but possible — always confirm by a second method.
- Syphilis false positive: cross-reactivity in some conditions; confirm with non-treponemal test.
Confirmatory testing
HIV: confirmatory per national algorithm (differentiation assay or molecular). Syphilis: confirm/stage with a non-treponemal test (RPR/VDRL).
Procurement considerations
Combined HIV + syphilis devices reduce steps in antenatal and blood-bank screening; both markers follow their own confirmation pathway.
Related pages
Which test to choose
Screen for both together in at-risk and antenatal populations — they share risk groups and are frequently co-tested in one combo device.
Last reviewed: 2026-09-12